Lupin Unveils Game-Changing Risperidone Injectable with Exclusive CGT in the U.S. Lupin Limited has launched a revolutionary Risperidone long-acting injectable, gaining exclusive CGT for 180 days in the U.S., marking a new era in treatment.

Lupin Unveils Game-Changing Risperidone Injectable with Exclusive CGT in the U.S. #United_States #Florida #Lupin_Limited #risperidone #PrecisionSphere

Lupin Unveils Strategic Partnership Program to Expand PrecisionSphere™ Injectable Platform Lupin Limited has launched a program aimed at enhancing the PrecisionSphere™ injectable platform's global reach. The initiative focuses on strategic partnerships, promising innovative health solutions.

Lupin Unveils Strategic Partnership Program to Expand PrecisionSphere™ Injectable Platform #India #Mumbai #Lupin_Limited #Nanomi_B.V. #PrecisionSphere

Lupin Unveils Strategic Partnership Program to Expand Injectable Solutions Reach Lupin Limited has launched a strategic partnership initiative aimed at broadening the reach of its long-acting injectable platform, PrecisionSphere™, enhancing patient access.

Lupin Unveils Strategic Partnership Program to Expand Injectable Solutions Reach #India #Mumbai #Nanomi #Lupin_Limited #PrecisionSphere

Lupin Launches Strategic Program to Enhance Long-Acting Injectable Platform Reach Lupin Limited announces a new strategic partnership program to extend its long-acting injectable platform, PrecisionSphere™, to enhance patient access to effective treatments.

Lupin Launches Strategic Program to Enhance Long-Acting Injectable Platform Reach #India #Mumbai #Lupin #PrecisionSphere #Long-Acting_Injectable

Lupin Introduces Innovative Partnership Program for Long-Acting Injectable Expansion Lupin Limited has launched a strategic partnership program to broaden the reach of its innovative long-acting injectable platform, PrecisionSphere™.

Lupin Introduces Innovative Partnership Program for Long-Acting Injectable Expansion #India #Mumbai #Nanomi #Lupin #PrecisionSphere